Electra Therapeutics
SIRP-targeting antibody that depletes pathological immune cells
Follows are private to you and power your alerts
Updated · electra-therapeutics.com
- Sector
- Biotech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Latest Form D
- $134M, Oct 2025
- Total capital
- $134M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $134M
- 1 Form D · last Oct 2025
- 12 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 17 pending · first 2025
- Rank in peer group#397 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$134M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#397 · top 27%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Beth Seidenberg, M.D.DirectorNamed in SEC Form D filings
- Carl Gordon, Ph.D.DirectorNamed in SEC Form D filings
- Matthew FustDirectorNamed in SEC Form D filings
- Nancy Stagliano, Ph.D.DirectorNamed in SEC Form D filings
- Quehuong (Kathy) Dong, Pharm.D.Executive Officer, DirectorNamed in SEC Form D filings
- Thomas Geninatti, Ph.D.DirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 19- GrantedSirp Alpha, Sirp Beta 1, And Sirp Gamma Antibodies And Uses ThereofUSPTOUS 12,503,508
- PendingSirp Alpha, Sirp Beta 1, And Sirp Gamma Antibodies And Uses ThereofUSPTOApplication 18963213
- GrantedSirp Alpha, Sirp Beta 1, And Sirp Gamma Antibodies And Uses ThereofUSPTOUS 12,187,797
Show all 19 patent records
- Sirp Alpha, Sirp Beta 1, And Sirp Gamma Antibodies And Uses ThereofDec 23, 2025 · US 12,503,508Granted
- Sirp Alpha, Sirp Beta 1, And Sirp Gamma Antibodies And Uses ThereofJun 19, 2025 · Application 18963213Pending
- Sirp Alpha, Sirp Beta 1, And Sirp Gamma Antibodies And Uses ThereofJan 7, 2025 · US 12,187,797Granted
- Sirp Gamma Antibodies And Uses ThereofDec 5, 2024 · Application 18660086Pending
- Sirp Alpha And Sirp Beta 1 Antibodies And Uses ThereofJun 8, 2023 · Application 17923781Pending
- Sirp Antibodies For Treatment Of CancerApplication 63591737Pending
- Sirp Antibodies For Treatment Of Hemophagocytic LymphohistiocytosisApplication 63591736Pending
- Sirp Gamma Antibodies And Uses ThereofApplication PCTUS2022079668Pending
- Sirp Gamma Antibodies And Uses ThereofApplication 63277966Pending
- Sirp Alpha And Sirp Beta 1 Antibodies And Uses ThereofApplication PCTUS2021031541Pending
- Sirp Alpha, Sirp Beta 1, And Sirp Gamma Antibodies And Uses ThereofApplication PCTUS2021031605Pending
- Sirp Alpha Antibodies And Uses ThereofApplication 63022309Pending
- Sirp Antibodies For Treatment Of Hemophagocytic LymphohistiocytosisApplication 19579890Pending
- Sirp Gamma Antibodies For Treatment Of Epstein-barr Virus InfectionsApplication PCTUS2025025784Pending
- Sirp Antibodies For Treatment Of CancerApplication 19579891Pending
- Sirp Alpha, Beta, Gamma Antibodies For Treatment Of Epstein–barr Virus InfectionsApplication PCTUS2025025772Pending
- Sirp Antibodies For Treatment Of CancerApplication PCTUS2024052127Pending
- Sirp Antibodies For Treatment Of Hemophagocytic LymphohistiocytosisApplication PCTUS2024052123Pending
- Sirp Antibodies For Treatment Of Epstein-barr Virus InfectionsApplication 63637314Pending
Related companies, and why
- CRIMSON BIOPHARM INCSimilar federal contract value in Biotech · null in contracts
- Cyteir Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Nuvalent, Inc.Similar federal contract value in Biotech · null in contracts
- Caribou BiosciencesSimilar federal contract value in Biotech · null in contracts
- Sirnaomics, Inc.Similar federal contract value in Biotech · null in contracts
- Terrestrial Bio, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .